Figure 1
Patients with higher TS gene expression in primary tumor cells had longer median relapse-free and overall survival (P = 0.030 and P = 0.029).
Figure 1 | Journal of Hematology & Oncology
Patients with higher TS gene expression in primary tumor cells had longer median relapse-free and overall survival (P = 0.030 and P = 0.029).